Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Metastatic Urothelial Cancer × sirtratumab vedotin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Urothelial Cancer 1

Interventions

pembrolizumab 2 enfortumab vedotin 2 Gemcitabine 2 Carboplatin 2 zimberelimab 1 sirtratumab vedotin 1 sacituzumab govitecan 1 olaparib 1 avelumab 1 Oxaliplatin 1 Nivolumab 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01963052 2024-11-01

ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer

Astellas Pharma Inc

Phase 1 Completed

Metastatic Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡